JournalsHub
.online
Find My Journal
AH

Axel Hauschild

Christian-Albrechts-Universität zu Kiel DE

ORCID iD 0000-0002-1212-9587
811
Publications
72,777
Citations
110
H-Index
411
i10-Index
14.25
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

806 total

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study PDF

Georgina V. Long, Keith T. Flaherty, Daniil Stroyakovskiy, Helen Gogas, E. Levchenko et al. - Annals of Oncology, 2017
Cited by 648 OpenAlex

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

Jason Chesney, Igor Puzanov, Frances A. Collichio, Parminder Singh, Mohammed Milhem et al. - Journal of Clinical Oncology, 2017
Cited by 610 OpenAlex

Melanoma

Dirk Schadendorf, David E. Fisher, Claus Garbe, Jeffrey E. Gershenwald, Jean‐Jacques Grob et al. - Nature Reviews Disease Primers, 2015
Cited by 590 OpenAlex

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma PDF

Antoni Ribas, Richard Kefford, Margaret Marshall, Cornelis J.A. Punt, John B.A.G. Haanen et al. - Journal of Clinical Oncology, 2013
Cited by 813 OpenAlex

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

Paolo A. Ascierto, Dirk Schadendorf, Carola Berking, Sanjiv S. Agarwala, Carla M.L. van Herpen et al. - The Lancet Oncology, 2013
Cited by 642 OpenAlex

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up PDF

Reinhard Dummer, Axel Hauschild, Merlin Guggenheim, U. Keilholz, G. Pentheroudakis - Annals of Oncology, 2012
Cited by 717 OpenAlex

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Alexander M.M. Eggermont, Stefan Suciu, Mario Santinami, Alessandro Testori, Wim H.J. Kruit et al. - The Lancet, 2008
Cited by 642 OpenAlex

Research Topics

Cutaneous Melanoma Detection and Management (371) Melanoma and MAPK Pathways (296) CAR-T cell therapy research (165) Nonmelanoma Skin Cancer Studies (155) Cancer Immunotherapy and Biomarkers (125)

Affiliations

Goethe University Frankfurt
DE 2010 - 2003
European Organisation for Research and Treatment of Cancer
NL 2007 - 2007
The University of Sydney
AU 2012 - 2012
Deaconess Hospital
US 2010 - 2010
Beth Israel Deaconess Medical Center
US 2010 - 2010

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now